首页|猴痘病毒A29L-A35R-M1R融合蛋白的原核表达、纯化及免疫原性初步分析

猴痘病毒A29L-A35R-M1R融合蛋白的原核表达、纯化及免疫原性初步分析

扫码查看
猴痘病毒(Monkeypox virus,MPXV)是一种能够感染人和动物的痘病毒,已对人类公共卫生安全构成巨大威胁,安全高效的疫苗能够有效预防和控制病毒的传播.本研究选取MPXV A29L、A35R和M1R氨基酸序列通过柔性Linker(GGGGS)连接设计融合蛋白,并根据大肠杆菌密码子偏嗜性对其密码子优化后合成全基因,插入pET-28a载体,构建pET28a-A29L-A35R-M1R重组质粒.转化至E.coli BL21(DE3)感受态细胞中诱导表达,经SDS-PAGE和Western blot进行鉴定,并确定最佳诱导条件.在此基础上,对融合蛋白rA29L-A35R-M1R进行Ni-NTA亲和层析柱纯化后,免疫小鼠.通过ELISA方法检测抗MPXV A29L、A35R和M1R特异性IgG和细胞因子(IFN-γ、IL-2和IL-4)水平,评价融合蛋白免疫原性.实验结果显示:重组质粒pET-28a-A29L-A35R-M1R在E.coli BL21(DE3)感受态细胞中成功表达,最佳表达条件为37 ℃、0.25 mmol/L IPTG诱导5h;将纯化的融合蛋白rA29L-A35R-M1R免疫小鼠3次后,能够产生抗A29L、A35R和M1R特异性IgG,其中anti-rA29L-A35R-M1R IgG水平最高,且融合蛋白rA29L-A35R-M1R能够刺激机体产生高水平IFN-γ,IL-2和IL-4,与对照组差异均具有统计学意义(P<0.01).由此表明,融合蛋白 rA29L-A35R-M1R具有良好的免疫原性.为猴痘病毒新型疫苗和治疗性生物制剂的研发提供理论依据.
Prokaryotic Expression,Purification and Preliminary Immunogenicity Analyses of the A29L-A35R-M1R Fusion Protein of the Monkeypox Virus
The monkeypox virus(MPXV)is a poxvirus that can infect humans and animals.The MPXV poses a significant threat to public-health security.A safe and efficacious vaccine is needed to prevent and control the spread of the MPXV.The amino-acid sequences of A29L,A35R and M1R of the MPXV were selected to design fusion proteins using a flexible peptide(GGGGS)linkage.The whole gene was synthesized after codon optimization according to Escherichia coli codon bias,inserted into the pET-28a vector,and then we constructed the pET28a-A29L-A35R-M1R recombinant plasmid.Expression was induced by transformation into E.coli BL21(DE3)receptor cells,characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blotting,and the optimal induction conditions were determined.On this basis,the fusion protein rA29L-A35R-M1R was purified by Ni-NTA affinity chromatography and immunized to mice.The immunogenicity of fusion proteins was evaluated by measuring the levels of anti-MPXV A29L,A35R and M1R-specific immunoglobulin(Ig)G and cytokines(interferon(IFN)-γ,interleukin(IL)-2 and(IL)-4)by enzyme-linked immunosorbent assays.The recombinant plasmid pET-28a-A29L-A35R-M1R was expressed in E.coli BL21(DE3)receptor cells.The optimal conditions for expression were use of IPTG(0.25 mmol/L)at 37℃ for 5 h.After immunizing mice thrice with the purified fusion proteins rA29L-A35R-M1R,mice could produce anti-A29L,A35R and M1R-specific IgG.The level of anti-rA29L-A35R-M1R IgG was the highest.The fusion protein rA29L-A35R-M1R could stimulate the body to produce high levels of IFN-γ,IL-2 and IL-4,and the differences in levels compared with those in the control group were all highly significant(P<0.01).These data indicate that the fusion protein rA29L-A35R-M1R had good immunogenicity.Our results provide a theoretical basis for the development of novel vaccines and therapeutic biological agents for the MPXV.

Monkeypox virusFusion proteinProkaryotic expressionImmunogenicity

张晓凤、高志峰、王紫研、夏伯阳、马鸣潇、费东亮

展开 >

锦州医科大学畜牧兽医学院,锦州 121000

辽宁省农业发展服务中心,沈阳 110015

猴痘病毒 融合蛋白 原核表达 免疫原性

国家重点研发计划

2023YFD1800404

2024

病毒学报
中国微生物学会

病毒学报

CSTPCD北大核心
影响因子:1.046
ISSN:1000-8721
年,卷(期):2024.40(5)